Results 221 to 230 of about 8,910 (238)

The Strategy of NPM

2010
openaire   +1 more source

What have we learnt from mouse models of NPM-ALK-induced lymphomagenesis?

Leukemia, 2005
Suzanne D Turner
exaly  

NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma

Cancers, 2019
Moinul Haque, Yung-Hsing Huang, Adam R Karpf   +2 more
exaly  

Governance innovation as social imaginaries: challenges of post-NPM

Public Management Review
Elin K Funck, Tom S Karlsson
exaly  

Relocation of NPM Affects the Malignant Phenotypes of Hepatoma SMMC‐7721 Cells

Journal of Cellular Biochemistry, 2017
Dong-Hui Xu, Qi-Fu Li, Song-Lin Shi
exaly  

The NPM-ALK tyrosine kinase mimics TCR signalling pathways, inducing NFAT and AP-1 by RAS-dependent mechanisms

Cellular Signalling, 2007
Suzanne D Turner, Simon J Cook, Denis R Alexander   +2 more
exaly  

NPM–RAR, not the RAR–NPM reciprocal t(5;17)(q35;q21) acute promyelocytic leukemia fusion protein, inhibits myeloid differentiation

Leukemia and Lymphoma, 2014
Robert L Redner
exaly  

NPM–ALK

2011
openaire   +1 more source

Interaction with RXR is necessary for NPM-RAR-induced myeloid differentiation blockade

Leukemia Research, 2013
Robert L Redner
exaly  

NPM 2.0

2020
Sforza, Vincenzo, Stefanoni, Alessandra
openaire   +1 more source